In vitro synergic effect of β-lapachone and isoniazid on the growth of Mycobacterium fortuitum and Mycobacterium smegmatis

Memorias do Instituto Oswaldo Cruz

Volumn 104, Issue 4, 2009, Pages 580-582

  da Silva, Joas L ^a   Mesquita, Amanda R C ^a   Ximenes, Eulalia A ^a  

^a DEPARTAMENTO DE MICOLOGIA   (Brazil)

Author keywords

Antimycobacterial activity; Isoniazid; Nontuberculous mycobacteria; lapachone

Indexed keywords

ATYPICAL MYCOBACTERIUM; BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; MYCOBACTERIUM; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM SMEGMATIS;

EID: 70149091931     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/s0074-02762009000400008     Document Type: Article

References (18)

1. Akhtar P, Srivastava S, Srivastava A, Srivastava M, Srivastava BS, Srivastava R 2006. Rv3303c of Mycobacterium tuberculosis protects tubercle bacilli against oxidative stress in vivo and contributes to virulence in mice. Microbes Infect 8: 2855-2862.
2. Brendan L, Wilkinson LFB, Anthony DW, Houston TA, Sally-Ann P 2007. Anti-mycobacterial activity of a bis-sulfonamide 2007. Bioorg Med Chem Letters 17: 1355-1357.
3. Bulatovic VM, Wengenack NL, Uhl JR, Hall L, Roberts GD, Cockerill FR, Rusnak F 2002. Oxidative stress increases susceptibility of Mycobacterium tuberculosis to isoniazid. Antimicrob Agents Chemoter 46: 2765-2771.
4. Chung MJ, Lee KS, Koh WJ, Kim TS, Kang EY, Kim SM, Kwon OJ, Kim S 2006. Drug-sensitive tuberculosis, multidrug-resistant tuberculosis and nontuberculous mycobacterial pulmonary disease in non AIDS adults: comparisons of thin-section CT findings. Eur Radiol 16: 1934-1931.
5. Cruz FS, Docampo R, Boveris A 1978. Generation of superoxide anions and hydrogen peroxide from β-lapachone in bacteria. Anti-microb Agents Chemother 14: 630-633.
6. D'albuquerque IL, Maciel MCN, Schuler ARP, Araujo MCM, Maciel GM, Cavalcanti MSB, Martins DG, Lacerda AL 1972. Preparação e primeiras observações sobre as propriedades antibióticas e antineoplásicas das naftoquinonas homólogos inferiores na série da 2-hidróxi-3-(3-metil-2-2-butenil)-1,4-naftoquinona(lapachol). Rev Inst Ant 12: 31-40.
7. Gupta AK, Chauhan DS, Srivastava K, Das R, Batra S, Mittal M, Goswami P, Singhal N, Sharma VD, Venkatesan K, Hasnain SE, Katoch VM 2006. Estimation of efflux mediated multi-drug resistance and its correlation with expression levels of two major efflux pumps in mycobacteria. J Commun Dis 38: 246-254.
8. Krogstad DJ, Moellering RC 1986. Antimicrobial combinations. In V Lorian, Antibiotics in laboratory medicine, 2nd ed., Williams & Wilkins, Baltimore, p. 537-557.
9. Maheshwari R 2007. Combating antibiotic resistance in bacteria by combination drug therapy. Cur Science 92: 1478.
10. Mdluli K, Swanson J, Fischer E, Lee RE, Barry CE 3rd 1998. Mechanisms involved in the intrinsic isoniazid resistance of Mycobacterium avium. Mol Microbiol 27: 1223-1233.
11. NCCLS - National Committee for Clinical Laboratory Standards 1990. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 2nd ed., Approved Standard, Villanova, M7- A2.
12. Nuermberger E, Grosset J 2004. Pharmacokinetic and pharmacodynamic issues in the treatment of mycobacterial infections. Eur J Clin Microbiol Infect Dis 23: 243-255.
13. Porat MD, Austin MS 2008. Bilateral knee periprosthetic infection with Mycobacterium fortuitum. J Arthroplasty 23: 787-789.
14. Prendki V, Germaud P, Bemer P, Masseau A, Hamidou M 2008. Les infectious a mycobactéries non tuberculeuses. La Revue de Médicine Interne 29: 370-379.
15. Salas C, Tapia RA, Ciudad K, Armstrong V, Orellana M, Kemmerling U, Ferreira J, Maya JD, Morello 2008. Trypanosoma cruzi: activities of lapachol and α- and β-lapachona derivatives against epimastigote and trypomastigote forms. Bioorg Med Chem 16: 668-674.
16. Silva Junior EN, Souza MCBV, Fernandes MC, Menna-Barreto RFS, Pinto MCFR, Lopes FA, Simone CA, Andrade CKZ, Pinto AV, Ferreira VF, Castro SL 2008. Synthesis and anti-Trypanosoma cruzi activity of derivatives from nor-lapachones and lapachones. Bioorg Med Chem 16: 5030-5038.
17. Tran T, Saheba E, Arcerio AV, Chavez V, Li Q, Martinez LE, Prim TP 2004. Quinones as antimycobacterial agents. Bioorg Med Chem 12: 4809-4813.
18. Zhang Y, Heym B, Allem B, Young D, Cole ST 1992. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358: 591-593.